Press release
PharmaResearch Announces 'Open Innovation Day' Running Until September 30 to Foster New Partnerships
Image: https://www.getnews.info/uploads/3276751a42ffba8429fb959e81d25795.jpg
PharmaResearch, a company specializing in regenerative medicine (CEO Kim Thinkyou, Kang Ki-seock), announced that it will host the 'Open Innovation Day'. This initiative aims to foster collaborations in innovative technologies across the aesthetic medical device, pharmaceuticals, biotechnology sectors, both domestically and internationally.
PharmaResearch is seeking partnerships in several key areas, including - facial aesthetics, - body contouring, - aesthetic devices and technology, and - treatments for hair loss, obesity, and sarcopenia. Medical device, Pharmaceutical and biotechnology companies from around the world with innovative technologies and expertise in these fields are encouraged to apply.
PharmaResearch is actively seeking to establish various forms of partnerships with selected companies, including licensing agreements, joint development initiatives, and strategic investments.
A representative from PharmaResearch stated, "The Open Innovation Day is designed to support the continuous growth of companies with innovative ideas and technologies through collaboration. We will continue identifying promising companies and establishing cooperative frameworks for mutual growth."
Applications for participation are open from August 15 to September 30. Detailed information about the 'Open Innovation Day' can be found in the notice section on the PharmaResearch website (https://pharmaresearch.co.kr/en/notice/list.html).
Image: https://www.getnews.info/uploads/8234b2c31f2d327c24f8286c5e4bf35c.png
About PharmaResearch
PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. With a diverse portfolio encompassing medicines, medical devices, cosmetics, and supplements, PharmaResearch focuses on leveraging its core ingredients, DOT Registered PDRN and DOT Registered PN. These active tissue regenerative substances are powered by DOT Registered , an exclusive DNA fragments optimization technology safeguarded by a suite of patents. Headquartered in Seongnam, South Korea, PharmaResearch also operates a U.S. subsidiary, PharmaResearch USA, located in Costa Mesa, California.
Key products include Rejuran Registered , Rejuviel Registered , Conjuran Registered , Rejuran Registered Cosmetics, Lian Registered Eye Drops, Rejuvenex Cream Registered , and Rejuderma Registered .
For more information about PharmaResearch and its innovative initiatives, visit
http://pharmaresearch.co.kr/en/ and connect with us on LinkedIn [https://www.linkedin.com/company/pharmaresearch-corporation/].
Media Contact
Company Name: PharmaResearch USA
Contact Person: Sangjin Choi
Email: Send Email [http://www.universalpressrelease.com/?pr=pharmaresearch-announces-open-innovation-day-running-until-september-30-to-foster-new-partnerships]
Country: United States
Website: http://pharmaresearch.co.kr/en/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PharmaResearch Announces 'Open Innovation Day' Running Until September 30 to Foster New Partnerships here
News-ID: 3651324 • Views: …
More Releases from Getnews
"Legacy" Receives Esteemed Literary Titan Gold Book Award, Marking a Major Miles …
Image: https://www.globalnewslines.com/uploads/2025/12/1767209542.jpg
Legacy , the debut novel in an ambitious science-fantasy series by The Chronicler, has been honored with the Literary Titan Gold Book Award, recognizing its powerful storytelling, immersive world-building, and emotionally driven characters.
Set on the war-torn world of Utopia, Legacy introduces readers to a universe where ancient magic coexists with advanced technology, and where young warriors are forced to confront war, loyalty, love, and loss far earlier than they…
Frank Elsner Spotlighted for His Leadership Insights on Preparedness, Clarity, a …
Chief of Safety and Security Shares Lessons on Decision-Making, Personal Resets, and Building Stronger Communities Through Simple Daily Habits
Frank Elsner, Chief of Safety and Security for the Natural Factors Group of Companies, has been featured in a new profile highlighting his approach to leadership, decision-making, and personal preparedness. The in-depth discussion explores how his diverse experiences-ranging from intelligence roles to executive leadership-shaped his views on awareness, resilience, and intentional daily…
Dr. Earl Davis, Jr. Calls for National Workforce Reawakening in Response to Ford …
Olympic Torchbearer, Trusted Advisor to World Leaders, and Financial Intercessor Urges Bold Partnerships to Ignite America's Talent
Ford's Unfilled Skilled-Labor Jobs Spark Visionary Response from Dr. Earl Davis, Jr.
In light of recent comments made by Ford CEO Jim Farley on his widely followed podcast, highlighting the automaker's struggle to fill 5,000 skilled-labor positions, Dr. Earl Davis, Jr.-Olympic Torchbearer, distinguished advisor to world leaders, and renowned financial intercessor-has issued a powerful call…
Mobile Locksmith TX Offers On-Call Locksmith Support Across Houston
Image: https://www.globalnewslines.com/uploads/2025/12/1767200743.jpg
Providing residential, commercial, automotive, and emergency locksmith services with fast response times, Mobile Locksmith TX supports homeowners, drivers, and businesses throughout Houston with dependable mobile solutions.
Lock and key problems often happen without warning, whether it's a late-night lockout, a broken office lock, or a misplaced car key. Mobile Locksmith TX has built its reputation around responding quickly to these everyday emergencies by bringing professional locksmith services directly to homes,…
More Releases for PharmaResearch
Polynucleotides Injectable Overview and Leading Players: Euroresearch S, NeoGene …
The Polynucleotides Injectable market is rapidly gaining traction as a pivotal segment within the aesthetic and medical sectors. Polynucleotides, naturally occurring polymers of nucleotides, have emerged as a revolutionary ingredient in injectables, primarily due to their ability to stimulate tissue regeneration and enhance skin hydration. The relevance of this market is underscored by its applications in various therapeutic and aesthetic procedures, including skin rejuvenation, wrinkle reduction, and overall facial volumization.
𝐘𝐨𝐮…
PharmaResearch Hosts 5th Global Symposium on 'Rejuran'
Over 600 Medical Professionals from 25 Countries Participate, Launch of IRC Committee for Rejuran Global Research Team
Image: https://www.getnews.info/uploads/184db9fd8e5f5bcffadcfd0b82962264.png
Seongnam, South Korea - PharmaResearch (CEO Ki Seock Kang and Thinkyou Kim) announced today that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on October 28-29, 2024. This year's event attracted approximately 600 aesthetic and medical professionals from 25 countries across Asia, the Americas, Europe, and the…
PharmaResearch Accelerates Global Market Expansion with Investment from Global P …
Accelerating Overseas Expansion and Market Strengthening through CVC Partnership, M&As, and R&D Investments
Image: https://www.getnews.info/uploads/37d3d1ec3a03e85dac6376b2c2e3bb4e.jpg
September 13th, 2024 - PharmaResearch (co-CEOs: Kang Ki Seock, Kim Thinkyou), a leader in aesthetic injectables and regenerative medicines renowned for its flagship skin booster product "Rejuran", announced a significant milestone in its global market expansion efforts, securing KRW 200 billion investment from Europe-based global private equity firm CVC through the issuance of redeemable convertible preferred shares…
PharmaResearch Hosts Launch Symposium for REJURAN Registered HB Plus in Singapor …
Sharing information on DOT Trademark patented technology, distinctive efficacy, and safety
Image: https://www.getnews.info/uploads/a9dbc52352e6614785a6dbafd0148817.png
PharmaResearch (CEOs Kang Ki-seok and Kim Thinkyou), a company specializing in regenerative medicine, announced earlier this month that it held a launch symposium for REJURAN Registered HB Plus at Four Seasons Hotel in Singapore.
The symposium aimed to share the technological advancements and clinical experiences of REJURAN Registered HB Plus with local aesthetic experts and medical professionals.
Dr. Michael J. Kim,…
PharmaResearch Presents 'REJURAN Registered ' as a New Solution for Flushing
Effective Use of PN for Flushing... Published in an SCIE-Level Journal
Image: https://www.getnews.info/uploads/52b03d248c2ca7ae3fdd1f69ef67ba5c.png
Flushing refers to the temporary or persistent redness of the skin on the face and neck. It occurs due to vasodilation and is known to arise from various causes, such as hormonal changes, sudden temperature fluctuations, inflammatory skin diseases, and prolonged laser treatments.
While laser and hormone therapies are common treatments for flushing, PharmaResearch(CEO Kim Thinkyou, Kang Ki-seok) has recently…
PharmaResearch, "Rejuran Registered " Accelerates Entry into Vietnam
Rejuran Launch Symposium Highlights Latest Aesthetic Trends and DOT Trademark Technology
Image: https://www.getnews.info/uploads/94717ca7a950a52ac08fd7e65857e556.jpg
PharmaResearch (CEO Kim Thinkyou, Kang Ki-seok) announced the official entry into the Vietnamese market through the 'Rejuran Launch Symposium' held on May 17 at the Intercontinental Vietnam.
The symposium was attended by over 400 Vietnamese aesthetic experts and medical professionals who validated the excellence of Rejuran and engaged in in-depth discussions on its application methods.
'Rejuran' is a medical device aimed…
